Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danni L Harris

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Opinion in Drug Discovery & Development|February 26, 2004
In silico predictive metabolism: a structural/electronic filter methodDanni L Harris
Journal of Inorganic Biochemistry|September 19, 2002
Oxidation and electronic state dependence of proton transfer in the enzymatic cycle of cytochrome P450eryFDanni L Harris
Biochemistry|March 9, 2005
P450 active site architecture and reversibility: inactivation of cytochromes P450 2B4 and 2B4 T302A by tert-butyl acetylenesAnna L Blobaum, Danni L Harris, Paul F Hollenberg
Journal of Medicinal Chemistry|June 24, 2015
Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for DiscoverySanju Narayanan, Danni L Harris, Rangan Maitra, et al.
Proteins|May 18, 2004
Theoretical study of the ligand-CYP2B4 complexes: effect of structure on binding free energies and heme spin stateDanni L Harris, Jin-Young Park, Larry Gruenke, et al.
ACS Chemical Neuroscience|August 9, 2016
Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling StudiesChunyang Jin, Ann M Decker, Danni L Harris, et al.
Journal of the American Chemical Society|February 14, 2002
Proton-transfer dynamics in the activation of cytochrome P450eryFVictor Guallar, Danni L Harris, Victor S Batista, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2023
The development of diphenyleneiodonium analogs as GPR3 agonistsElaine A Gay, Danni L Harris, Joseph W Wilson, et al.
Bioorganic & Medicinal Chemistry|April 24, 2014
Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activityYanyan Zhang, Rangan Maitra, Danni L Harris, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2006
Metabolism of bergamottin by cytochromes P450 2B6 and 3A5Ute M Kent, Hsia-lien Lin, Kathleen R Noon, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Opinion in Drug Discovery & Development|February 26, 2004
In silico predictive metabolism: a structural/electronic filter methodDanni L Harris
Journal of Inorganic Biochemistry|September 19, 2002
Oxidation and electronic state dependence of proton transfer in the enzymatic cycle of cytochrome P450eryFDanni L Harris
Biochemistry|March 9, 2005
P450 active site architecture and reversibility: inactivation of cytochromes P450 2B4 and 2B4 T302A by tert-butyl acetylenesAnna L Blobaum, Danni L Harris, Paul F Hollenberg
Journal of Medicinal Chemistry|June 24, 2015
Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for DiscoverySanju Narayanan, Danni L Harris, Rangan Maitra, et al.
Proteins|May 18, 2004
Theoretical study of the ligand-CYP2B4 complexes: effect of structure on binding free energies and heme spin stateDanni L Harris, Jin-Young Park, Larry Gruenke, et al.
ACS Chemical Neuroscience|August 9, 2016
Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling StudiesChunyang Jin, Ann M Decker, Danni L Harris, et al.
Journal of the American Chemical Society|February 14, 2002
Proton-transfer dynamics in the activation of cytochrome P450eryFVictor Guallar, Danni L Harris, Victor S Batista, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2023
The development of diphenyleneiodonium analogs as GPR3 agonistsElaine A Gay, Danni L Harris, Joseph W Wilson, et al.
Bioorganic & Medicinal Chemistry|April 24, 2014
Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activityYanyan Zhang, Rangan Maitra, Danni L Harris, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2006
Metabolism of bergamottin by cytochromes P450 2B6 and 3A5Ute M Kent, Hsia-lien Lin, Kathleen R Noon, et al.
Pageof 3